COMBINATION THERAPY OF CLAUDIN 18.2 ANTAGONIST AND PD-1/PD-L1 AXIS INHIBITOR
Publication
EP4433510A1
Kind: A1
Mar 18, 2026
Applicants
Suzhou Transcenta Therapeutics Co., Ltd., Transcenta Holding Limited, Transcenta Therapeutics, Inc.
Inventors
QIAN, Xueming, YAO, Xinlai, GUO, Huanhuan, TENG, Fei, YI, Wei
IPC Classifications
C07K 16/28 20060101AFI20260206BHEP
A61P 35/00 20060101ALI20260206BHEP
A61K 39/395 20060101ALI20260206BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR